Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom
2013 ◽
Vol 16
(10)
◽
pp. 1246-1254
◽
2019 ◽
Vol 35
(5)
◽
pp. 805-815
◽
2018 ◽
Vol 16
(1)
◽
2020 ◽
Vol 23
(7)
◽
pp. 751-759
◽
1999 ◽
Vol 81
(7)
◽
pp. 1243-1247
◽
2021 ◽
Vol 8
(2)
◽
pp. 63